Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications.
作者信息
Cohen Margo P, Ziyadeh Fuad N, Chen Sheldon
机构信息
University City Science Center, Philadelphia, Pennsylvania, USA.
出版信息
J Lab Clin Med. 2006 May;147(5):211-9. doi: 10.1016/j.lab.2005.12.006.
Abstract
摘要
相似文献
1
Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications.
J Lab Clin Med. 2006 May;147(5):211-9. doi: 10.1016/j.lab.2005.12.006.
2
Glycated Serum Albumin and AGE Receptors.
Adv Clin Chem. 2015;72:205-75. doi: 10.1016/bs.acc.2015.07.005. Epub 2015 Sep 19.
3
Pathophysiological role of Amadori-glycated proteins in diabetic microangiopathy.
Semin Vasc Med. 2002 May;2(2):191-7. doi: 10.1055/s-2002-32042.
4
Glycated serum albumin: a potential disease marker and an intermediate index of diabetes control.
Diabetes Metab Syndr. 2014 Oct-Dec;8(4):245-51. doi: 10.1016/j.dsx.2014.09.017. Epub 2014 Oct 11.
5
Minimizing spurious receptor-binding kinetics with modified proteins.
Anal Biochem. 1994 May 15;219(1):161-3. doi: 10.1006/abio.1994.1249.
6
Alpha-lipoate can protect against glycation of serum albumin, but not low density lipoprotein.
Biochem Biophys Res Commun. 1994 Aug 30;203(1):99-104. doi: 10.1006/bbrc.1994.2154.
7
Serum glycated lipoproteins in type II diabetic patients with and without complications.
Ann Clin Biochem. 1995 Sep;32 ( Pt 5):459-63. doi: 10.1177/000456329503200505.
8
Increased macrophage uptake of irreversibly glycated albumin modified-low density lipoproteins of normal and diabetic subjects is mediated by non-saturable mechanisms.
Biochim Biophys Acta. 1996 Oct 7;1317(1):5-14. doi: 10.1016/0925-4439(96)00017-8.
9
Advanced glycated albumin isolated from poorly controlled type 1 diabetes mellitus patients alters macrophage gene expression impairing ABCA-1-mediated reverse cholesterol transport.
Diabetes Metab Res Rev. 2013 Jan;29(1):66-76. doi: 10.1002/dmrr.2362.
10
An overview of in vitro and in vivo glycation of albumin: a potential disease marker in diabetes mellitus.
Glycoconj J. 2017 Oct;34(5):575-584. doi: 10.1007/s10719-017-9789-0. Epub 2017 Aug 15.
引用本文的文献
1
Glycation of Proteins and Its End Products: From Initiation to Natural Product-Based Therapeutic Preventions.
ACS Pharmacol Transl Sci. 2025 Feb 25;8(3):636-653. doi: 10.1021/acsptsci.4c00684. eCollection 2025 Mar 14.
2
Relationship between advanced glycation end-products and advanced oxidation protein products in patients with type 2 diabetes with and without albuminuria: A cross-sectional survey.
Health Sci Rep. 2024 Sep 29;7(10):e70057. doi: 10.1002/hsr2.70057. eCollection 2024 Oct.
3
Comparative pharmacokinetics of four major compounds after oral administration of Mori Cortex total flavonoid extract in normal and diabetic rats.
Front Pharmacol. 2023 Mar 1;14:1148332. doi: 10.3389/fphar.2023.1148332. eCollection 2023.
4
Attenuation of hyperglycemia and amadori products by aminoguanidine in alloxan-diabetic rabbits occurs via enhancement in antioxidant defenses and control of stress.
PLoS One. 2022 Jan 5;17(1):e0262233. doi: 10.1371/journal.pone.0262233. eCollection 2022.
5
In Vitro Evaluation of the Toxicological Profile and Oxidative Stress of Relevant Diet-Related Advanced Glycation End Products and Related 1,2-Dicarbonyls.
Oxid Med Cell Longev. 2021 Aug 8;2021:9912240. doi: 10.1155/2021/9912240. eCollection 2021.
6
Advanced glycation end products and their receptors in serum of patients with type 2 diabetes.
Sci Rep. 2021 Jun 24;11(1):13264. doi: 10.1038/s41598-021-92630-0.
7
Redox Signaling and Advanced Glycation Endproducts (AGEs) in Diet-Related Diseases.
Antioxidants (Basel). 2020 Feb 6;9(2):142. doi: 10.3390/antiox9020142.
8
Serum fructosamine, serum glycated albumin and serum glycated β-lipoprotein in type 2 diabetes mellitus patients with and without microvascular complications.
J Diabetes Metab Disord. 2016 Nov 21;15:53. doi: 10.1186/s40200-016-0276-0. eCollection 2016.
9
Glycated Albumin is Independently Associated With Arterial Stiffness in Non-Diabetic Chronic Kidney Disease Patients.
Medicine (Baltimore). 2016 Apr;95(16):e3362. doi: 10.1097/MD.0000000000003362.
10
Amadori albumin in diabetic nephropathy.
Indian J Endocrinol Metab. 2015 Jan-Feb;19(1):39-46. doi: 10.4103/2230-8210.146863.
本文引用的文献
1
Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy.
Kidney Int. 2005 Oct;68(4):1554-61. doi: 10.1111/j.1523-1755.2005.00567.x.
2
Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1.
Diabetes. 2005 Aug;54(8):2320-7. doi: 10.2337/diabetes.54.8.2320.
3
Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation.
Eur J Pharmacol. 2005 Apr 18;513(1-2):145-50. doi: 10.1016/j.ejphar.2005.02.010. Epub 2005 Apr 2.
4
Inflammation, atherosclerosis, and coronary artery disease.
N Engl J Med. 2005 Apr 21;352(16):1685-95. doi: 10.1056/NEJMra043430.
5
NMR analysis of synthetic human serum albumin alpha-helix 28 identifies structural distortion upon amadori modification.
J Biol Chem. 2005 Jun 17;280(24):22582-9. doi: 10.1074/jbc.M501480200. Epub 2005 Apr 18.
6
Identification of Amadori-modified plasma proteins in type 2 diabetes and the effect of short-term intensive insulin treatment.
Diabetes Care. 2005 Mar;28(3):645-52. doi: 10.2337/diacare.28.3.645.
7
Long-term taurine supplementation reduces mortality rate in streptozotocin-induced diabetic rats.
Amino Acids. 2004 Oct;27(2):187-91. doi: 10.1007/s00726-004-0108-2. Epub 2004 Aug 11.
8
Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature.
Proc Natl Acad Sci U S A. 2004 Oct 12;101(41):14871-6. doi: 10.1073/pnas.0406073101. Epub 2004 Oct 4.
9
A genome scan for diabetic nephropathy in African Americans.
Kidney Int. 2004 Oct;66(4):1517-26. doi: 10.1111/j.1523-1755.2004.00915.x.
10
Glycated albumin induces superoxide generation in mesangial cells.
Cell Physiol Biochem. 2004;14(4-6):361-8. doi: 10.1159/000080346.
Zotero 插件